Biomakers
PrivateLast Round
Series A
Jan 21, 2026
Total Funding Raised
$11M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biomakers operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in January 2026.
Biomakers is a biotechnology company that provides a precision medicine and oncology intelligence platform transforming clinical and genomic information into actionable insights for therapeutic and diagnostic development.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomakers Comparables
Compare Biomakers with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempus | 77% | |
| Verana Health | 76% | |
| Pahtia Technologies | 76% |
For institutional investors. Book with your work email.
Biomakers Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 21, 2026 | ||||
| Seed Round | Jan 26, 2024 | ||||
| SAFE | Dec 16, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biomakers Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zentynel Frontier Investments | Series A |
| Sonen Capital | Series A |
| SV Latam Capital | Series A, SAFE |
| Sky High VC | Series A |
| Oncology Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Raised $8M from Labcorp Venture Fund and others.
- Jan 26, 2024
Raised $6M in seed funding.
For institutional investors. Book with your work email.
Biomakers Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biomakers's valuation, stock price, and market status.
Is Biomakers a public or private company?
Biomakers is a private company.
What is the current stock price of Biomakers?
Biomakers is a private company, so its shares have no public market price. Caplight tracks Biomakers's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biomakers worth (valuation)?
Valuation information for Biomakers is not publicly available.
Can I buy Biomakers stock?
Biomakers shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biomakers's last funding round?
Biomakers's most recent funding round was Series A on January 21, 2026.
Who are the main investors in Biomakers?
Key investors in Biomakers include SV Latam Capital.
Will Biomakers IPO soon?
No public IPO plans have been announced for Biomakers.
How can I track Biomakers secondary market activity?
Caplight tracks bids, offers, and trades in Biomakers's shares on secondary markets.